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periplasmic expression of the immunoglobulin VL domain REI
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Background: Inclusion body (IB) formation in bacteria is an important example of
protein misassembly, a phenomenon which also includes folding-dependent
aggregation in vitro and amyloid deposition in human disease. Previous studies
of mutational effects in other systems implicate the stability of a folding
intermediate—rather than the native state—as playing a key role in IB formation. To
contribute to an understanding of the comparative biophysics of VL misassembly
in different biological settings, we have studied mutation-dependent periplasmic
IB formation by the VL domain REI in Escherichia coli.
Results: A series of mutants were produced in periplasmic IBs, where, in all
cases, the signal peptide was removed. In addition, the intradomain disulfide was
clearly formed before deposition into IBs. IB formation in these mutants does not
correlate with monomer/dimer equilibrium constants, but does correlate with the
thermodynamic stability of the native state. 
Conclusions: The results implicate a late, equilibrium folding intermediate in IB
formation, in contrast to the apparent involvement of transient folding
intermediates in other IB systems described to date. As equilibrium unfolding
intermediates have also been implicated in light chain amyloidosis and
deposition diseases, IB formation may prove a useful model for these human
diseases.
Introduction
The formation of insoluble aggregates is a ubiquitous part
of protein folding in vivo, as evidenced by the existence of
molecular chaperones [1], which function to block this
‘off-pathway’ aggregation. The process also plays a key
role in human diseases such as Alzheimer’s disease and
other amyloidosis [2], immunoglobulin deposition diseases
[3], and spongiform encephalopathies [4]. In biotechnol-
ogy, it is responsible not only for inclusion body (IB) for-
mation [5–7], but also for the in vitro aggregation that can
compromise efforts to retrieve native material from IBs
[8,9]. There is a growing body of evidence that these
aggregation processes in at least some instances possess
significant specificity, reflecting the operation of chain
configuration changes and packing interactions normally
associated with the productive part of the overall folding
pathway [10]. Such evidence, implicating a set of rules for
soluble folding over and above the rules controlling pro-
ductive folding specificity and stability [11], suggests that
protein misassembly may also constitute a major additional
hurdle in the design of novel proteins, and may thus
require both detailed analysis and a set of unique design
tools specifically aimed at the aggregation process [12].
One indication of this specificity is the existence of dra-
matic mutational effects on the severity of IB formation
[10]. The King group [13] has described ‘temperature-sen-
sitive folding’ (tsf) mutations in the salmonellaphage P22
tailspike protein that influence the extent of IB formation
without significantly affecting the folding stability or
activity of native protein produced under permissive (low
temperature) growth conditions. Similar mutants have
been described for interleukin-1b produced in Escherichia
coli [14]. In both cases, in vitro folding experiments repro-
duce the mutation and temperature-dependence of the
folding-related aggregation process [15,16]. The results
suggest that these mutations influence—in a manner not
yet elucidated—the rate-limiting steps that control kinetic
partitioning between productive assembly and misassem-
bly.
Misassembly relating to folding of the immunoglobulin VL
domain is of particular interest for several reasons.
Recently, we showed that introduction of mutations into
the hypervariable loops of the VL domain can have a large
impact on the folding stability and integrity of the domain
[17,18]; the extent to which such effects might influence
the folding efficiency of both the domain and the complete
immunoglobulin molecule is clearly of great biological
importance. IB formation greatly complicates attempts to
produce intact antibodies and antibody fragments in E. coli
[19,20]. The VL domain is also involved in several serious
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protein deposition phenomena in human disease [3].
Mutational studies suggest a strong role for destabilizing
sequence effects in these diseases [21,22], and it is thus of
considerable interest how the deposition of this domain in
humans compares in mechanism with the deposition of the
same domain leading to IB formation in E. coli.
We have constructed an expression system for the E. coli
production and periplasmic secretion of immunoglobulin
light chain variable domain REI VL [23] to use as a pre-
sentation scaffold for display of bioactive peptides
[17,18,24,25]. In this system, the wild-type molecule is
expressed in the soluble fraction and can be released from
the cell by osmotic shock. Many REI mutants, involving
both point mutations and sequence insertions, result in
substantial IB formation, however. In this paper, we report
in vitro analysis of the thermodynamic stabilities and
monomer/dimer equilibria of a set of REI VL sequence
variants and consider how these properties might influ-
ence IB levels. These results, in addition to data indicat-
ing the subcellular localization of the IBs and the extent of
disulfide bond formation in the IBs in the cell, allow us to
construct a working model for the mechanism of IB forma-
tion in this system.
Results
Previously, we have described an expression system for
REI VL in which wild-type and mutant sequences were
deposited in IBs in the E. coli cytoplasm and which
required denaturant solubilization and refolding—with
concomitant formation of the intramolecular disulfide—
for production of native protein [24]. As disulfide-medi-
ated refolding and its analytical validation proved difficult
and tedious, we constructed a derivative vector in which
78 Folding & Design Vol 1 No 2
Figure 1
SDS polyacrylamide gels on subcellular fractionation of E. coli
producing REI VL sequence variants. (a) Lanes 1 and 5, MW
standards; lanes 2 and 6, REI WT, purified; lanes 3 and 7, tac vector
minus REI gene; lanes 4 and 8, tac vector with WT REI gene; lanes 3
and 4, total cellular protein; lanes 7 and 8, osmotic shock fraction. 
(b) Native lysis supernatants and pellets showing distribution into IBs
of various mutants. Lanes as marked. Loading of some pellet lanes is
disproportionately high, compared with supernatant lanes, to improve
quantitation.
expression is controlled by the tac promoter and newly
synthesized protein is directed into the periplasm via the
pelB [26] signal sequence.
Wild-type REI VL is produced by cells transformed with
this vector at yields of at least 10 mg l–1 of low-density
(2 A600) shake flask culture. Figure 1a shows that wild-
type REI VL is released from the cells by osmotic shock.
In contrast, when the VL mutant REI-RGD4 is produced,
none is released by osmotic shock (not shown), and essen-
tially all of the protein distributes into the pellet of a
native cell lysate (Fig. 1b). This pellet has the milky white
appearance that is characteristic of a preparation of IBs. In
addition, electron microscopy of induced cells clearly
shows the electron-dense IBs (Fig. 2). REI-RGD4 IBs
produced from DNA not encoding a signal peptide [24]
are located in the cytoplasm (Fig. 2a). In contrast, the IBs
from REI produced with a signal peptide (Fig. 2b) are
clearly separated from the cytoplasm by a membrane, indi-
cating their periplasmic location. Periplasmic IBs have
been previously reported in the overexpression of b-lacta-
mase in E. coli [27].
We found wild-type REI VL to be difficult to purify by
standard chromatographic methods and to not elute from a
reverse phase C8 column in the standard trifluoroacetic
acid (TFA) system. However, the protein chromatographs
with good resolution and recovery on a C4 column and
preparative C4 HPLC were used to purify all the proteins
described in this study. Although the chromatography
yields highly purified material when used directly on
osmotic shock fractions, uncharacterized E. coli compo-
nents in these solutions poison the reverse phase resin,
which rapidly deteriorates to give poor resolution and high
back pressures. We found that a preliminary clean-up of
the osmotic shock solution with Amberlite (XAD-7,
Sigma) removes these components, dramatically extend-
ing column life. Exposure of the column to these fouling
components is also avoided when protein is purified from
the IB fraction, as soluble components from E. coli are
removed by centrifugation. For these proteins, guanidine
hydrochloride (Gdn-HCl) solubilized IB material was dia-
lyzed into 1 M urea buffer and loaded directly onto the
reverse phase column for preparative chromatography.
Wild-type REI VL purified from the soluble periplasmic
extract as described above is not only lacking the pelB
signal sequence, it also contains the desired intradomain
disulfide bond. This was shown by treating the protein
with iodoacetic acid (IAA) in the presence of Gdn-HCl,
dialyzing, and analyzing by laser desorption mass spec-
trometry (MS). The MS analysis gave a single major peak
for REI treated with IAA of 11904.3 Da, within experi-
mental uncertainty of the value obtained for non-IAA
treated, purified wild-type REI (11898.4 Da) as well as of
the calculated molecular weight for REI (11900.4 Da).
MS analysis of unstable mutant REI VL domains purified
from periplasmic IBs is also consistent with removal of the
signal peptide and formation of the disulfide (Table 1). In
the case of REI-RGD4, the presence of the disulfide bond
in the final, purified product was demonstrated both by
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Figure 2
Electron micrographs of REI-RGD4 VL
expressed in the (a) cytoplasm and (b)
periplasm of E. coli.
high-resolution electrospray MS (Table 1) and by the
inability of the protein to undergo a shift in the laser des-
orption MS parent ion on exposure of the solubilized IBs
to IAA (data not shown). The presence of the disulfide
bond in purified protein was also implied by the ability of
most mutants to exhibit the strongly quenched tryptophan
fluorescence characteristic of the immunoglobulin fold
after refolding from Gdn-HCl (the exception, REI-RGD4,
exhibits high fluorescence, not because the disulfide is not
formed, but because the disulfide-bonded state is non-
native even under mild conditions [17]).
Although all IB REI variants isolated to date contain the
intramolecular disulfide (data not shown), it remains possi-
ble that the disulfides are not present in the IBs in the
cell, but rather are formed during isolation subsequent to
cell lysis. The status of the cysteine residues of REI in
periplasmic IBs in the cell is of critical importance to
understanding the mechanism of in vivo protein folding
and IB formation. To confirm that disulfides are present
in IBs in the cell, we added IAA immediately after cell
lysis and solubilized the derived IBs in Gdn-HCl, also in
the presence of IAA. REI was purified from this Gdn-HCl
solution in the usual way. HPLC purification gave good
recovery of a single peak which gave a MS parent ion con-
sistent with disulfide-bonded, monomeric REI (Table 1).
In addition, amino acid composition analysis of the puri-
fied protein showed no evidence of carboxymethylcys-
teine (data not shown). As discussed next, we know
independently that carboxymethyl derivatives of REI
behave well in the HPLC step.
As a control, we lyzed cells and solubilized IBs containing
cytoplasmic REI-RGD4 in the same manner. MS of this
purified material gave a series of parent ions attributed to
iodoacetylated material (Table 1), confirming that the
cytoplasmic IBs contain REI in the reduced state and that
the employed assay conditions are sufficiently stringent to
avoid artifacts from oxidation during work-up.
Figure 3 is a ribbon diagram of the VL dimer from the REI
crystal structure [23], showing the sites mutated in this
study. Glutamine residues 38 and 89 take part in two sepa-
rate hydrogen bonding networks in the dimer interface.
Residues 41–43 are part of a b-bulge at the bottom of the
dimer interface. Residues 90–97 constitute CDR3 of the
molecule, flanking residues of which are also involved in
dimerization. These latter two sequences were replaced
with RGD sequences as part of a presentation scaffold
study previously described [24].
It is formally possible that the molecule responsible for IB
formation in the VL system is the native monomer, so that
mutants capable of highly populating the folded monomer
at equilibrium in the cell would be more susceptible to IB
formation than those that accumulate as dimers. To test
this we analyzed the wild type and several mutants for
efficiency of dimer formation. 
Figure 4 shows equilibrium sedimentation data for wild-
type REI VL at three rotor speeds. The data were globally
analyzed in terms of equation 4 (Materials and methods)
yielding a dissociation constant of 7.47±0.96× 10–6 M [28].
Figure 5 shows an analysis of REI-RGD4 data at
25000 rpm. Here, the data are analyzed in terms of equa-
tion 3b (Materials and methods) to generate a species analy-
sis. To determine the Kd values, the data were analyzed in
terms of equation 5. The total protein distribution is decon-
voluted into separate distributions for monomer, dimer and
tetramer based on an analysis in terms of the model.
Another way of visualizing the data is to plot the derived
relative concentrations of each species as a function of the
total monomer concentration (this is shown in Figure 5c).
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Table 1
Mass spectrometry on inclusion body derived REI-RGD4.*
Molecular species Expected MW Observed MW
Cytoplasmic inclusion bodies†, no IAA
fMet-Ala-REI VL 12933.7 12933.4
Met-Ala-REI VL 12902.66 NO
Ala-REI VL 12774.5 12774.2
Cytoplasmic inclusion bodies†, +IAA
fMet-Ala-REI-RGD4 VL 12933.7 NO
Met-Ala-REI-RGD4 VL 12902.66 NO
Ala-REI-RGD4 VL 12774.5 NO
fMet-Ala-REI-RGD4 VL, CM2, O‡ 13065.7 13066.7
Met-Ala-REI-RGD4 VL, CM2 13021.7 13018.9
fMet-Ala-REI-RGD4 VL, CM 12990.7 12990.3
Met-Ala-REI-RGD4 VL, CM 12963.7 12962.6
Ala-REI-RGD4 VL, CM2 12891.5 12898.7
Periplasmic inclusion bodies, no IAA§
REI-RGD4 VL 12701.1 12701.2 ± 0.7
Periplasmic inclusion bodies, +IAA
REI-RGD4 VL 12701.1 12700.5
REI-RGD4 VL, CM 12758.1 NO
REI-RGD4 VL, CM2 12815.1 NO
*See Materials and methods. Except where indicated, results were
obtained by MALDI-MS as described in Materials and methods. NO,
not observed; CM, carboxymethyl. †To obtain expression of REI in the
cytoplasm, it was necessary to add an initiator Met codon. The Ala
codon was added for cloning convenience (see [24]). ‡The single
oxygen required to derive the calculated MW could be associated
with Met oxidation. §This data is from electrospray MS, which has
sufficient resolution to detect the presence of two hydrogens were the
REI VL in the reduced state. The dominant peak in the MS of the
‘cytoplasmic inclusion bodies + IAA’ is the 12898 Da peak.
Kds and standard errors for each of the REI variants are
reported in Table 2. The wild-type data correspond to a
Ka of 1.4 × 105 M–1, consistent with the Kas of other VL
domains that have been reported [29] and within experi-
mental error of the Ka of 2.5 × 105 M–1 determined for the
same molecule (produced by a different method in E.
coli) by gel permeation chromatography profiles [30].
Table 2 shows that, although the replacement of Gln38
by Asp has no effect on Kd, the replacement of Gln89 by
Arg totally abrogates dimer formation within the limits of
the analysis. The mutant RGD6 leads to an increase in
the Kd (weaker dimer formation) by about an order of
magnitude. Finally, the CDR3 loop replacement RGD4
exhibits a Kd for the monomer/dimer equilibrium similar
to that of wild type, but in addition exhibits strong
tetramer formation. The molecular basis of tetramer for-
mation is not clear, and the data cannot be used to
address whether the dimeric component in RGD4 solu-
tions resembles the native dimer of the wild type or is a
non-native dimer on the pathway to non-native tetramer
formation.
Table 2 lists the percentage of REI found in the native
lysis supernatants and pellets of cells producing each of
the sequence variants described in this paper. The table
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Figure 3
Ribbon diagram of the structural model for the dimer of wild-type REI,
from the X-ray coordinate set 1REI [23] in the Brookhaven database
[46]. Chain A of the homodimer is in orange, chain B in green.
Positions involving mutations described in this paper are further
colored. Those at or near the dimer interface (residues 41–43 from
RGD6; Q38, Q89, and CDR3 from mutants RGD4 and 12) are in
shades of red, those distal to the interface (CDR1 portion altered in
RGD34, R61) are in purple.
also lists the Kd values for association equilibria deter-
mined by analytical ultracentrifugation. In general, the
data are not consistent with a hypothesis involving native
monomer in IB formation. Although REI-RGD6 exhibits
less strong dimer formation and higher IB levels than
wild type, and the Q89→R mutant is essentially inca-
pable of dimer formation and is a strong IB-former, other
sequence variants do not follow this trend. In particular,
two mutants which exhibit Kd values within experimen-
tal error of the wild type, REI(Q38→D) and REI-
RGD34, exhibit significantly higher IB levels than that
of wild type. 
An alternative explanation for the mutational control of IB
formation is that mutations compromise the folding stabil-
ity of these proteins, leading to the establishment of an
equilibrium between the native state and misfolded or
unfolded molecules with enhanced susceptibility to aggre-
gation. Each of the proteins in this study was subjected to
reversible unfolding using Gdn-HCl as a denaturant and
the fluorescence of the single tryptophan of the molecule
as a probe. The use of fluorescence as a probe allowed
examination of unfolding at low protein concentrations,
which not only discouraged aggregation in vitro during
unfolding, but also allowed the analysis to focus on the
folding stability of the monomer, which is favored at the
low concentrations at which these proteins were analyzed.
The denaturation midpoints and DDGstab values for these
proteins are listed in Table 2. As reported previously
[21,30], the wild type is relatively stable, with a DGstab of
–6 to –7 kcal mol–1. In contrast, REI-RGD4 is so unstable
that it exists substantially in a non-native form in native
buffer at RT and pH 7 [17].
Because it is advantageous to have direct Tm measure-
ments on these domains in order to relate in vitro experi-
ments to the proteins’ behavior under different cellular
growth temperatures, we also carried out thermal melts of
some of the REI sequence variants [17]. As expected [31],
thermal unfolding was not completely reversible; in fact,
the aggregation that accompanies thermal unfolding may
well be related to the IB formation process observed with
these molecules (see Discussion). The Tm values deriving
from these studies are listed in Table 2. Concentration-
dependent dimer formation by the VL domain would be
expected to increase the observed Tm values for determi-
nations at higher concentrations. It is difficult to estimate
the expected concentration of these VL domains in the
periplasm. It is conceivable that such concentrations may
be sufficiently high to encourage substantial dimer forma-
tion and thus provide additional stability over and above
the stabilities of the monomers reported here.
Figure 7 shows the relationship between IB formation and
stability of the REI variants described in this study. We
plot CM values here as relative measures of folding stabil-
ity. A similar trend is obtained if the DDGstab values from
Table 2 are used (not shown). A good correlation between
IB formation and domain stability is observed over a range
of IB formation from about 20% to nearly 100%, and over a
stability range from –7 kcal mol–1 to about 0 kcal mol–1 in
DGstab. A large number of REI mutants have been pro-
duced in this laboratory and the stabilities of many of
them to Gdn-HCl unfolding have been determined
([17,21]; LR Helms, R Wetzel, unpublished data).
Although rigorous quantitative analysis of the distribution
of most of these additional mutants between IB fraction
and soluble fraction has not been conducted, there is a
clear general correlation between low stability and high IB
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Figure 4
Equilibrium sedimentation data in the ultracentrifuge analysis of
association behavior of wild-type REI VL. Data reported here were
acquired at three rotor speeds at 25°C in a Beckman Optima XL-A
analytical ultracentrifuge. (a) The distributions of residuals for the fit of
the data to the model. The three panels in (a) are for 25, 20 and
15 000 rpm, respectively. (b) The primary data were obtained at 15,
20 and 25 000 rpm, respectively. The buffer was 20 mM sodium
phosphate, 150 mM NaCl, pH 7.4. The initial protein concentration
was ~18 mM (in terms of monomer concentration, i.e. A280 ~ 0.3).
These data were fit best to a monomer/dimer model, equation 4. The
value of K1,2 was determined to be 7.47 ± 0.96 × 10–6 M. 
formation, with all unstable mutants requiring purification
from the IB fraction in order to obtain useful amounts of
material (LR Helms, unpublished data).
Discussion
The high temperature coefficient of protein aggregation
[32] and proteolysis rates in vitro have traditionally been
interpreted as owing to a simple mechanism involving a
two-state pre-equilibrium between the native and
unfolded states, with the native state stable and the
unfolded state labile to the irreversible physical or chemi-
cal loss of solution-phase protein (for review, see [33]). In
analogy to this model, one class of temperature-sensitive
(ts) mutations has been interpreted as amino acid changes
that introduce reductions in thermodynamic stability suffi-
cient to allow the protein to access the unfolded state in
vivo, with commensurate irreversible inactivation (for dis-
cussion, see [34]). This was the historical context for the
discovery that tsf mutant forms of P22 tailspike protein are
molecules that accumulate more efficiently in IBs [13].
These proteins—which at restrictive temperatures are
incapable of accumulating in the cell as active protein
despite being stable, once formed, at much higher temper-
atures—must be compromised at some intermediate phase
of the protein folding reaction. Their existence allows one
to infer transient folding intermediates which are not pop-
ulated at equilibrium at cellular growth temperatures but
whose stabilities none the less influence relative extents of
protein maturation and protein deposition. Similar mutants
have been described for interleukin-1b [16].
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Figure 5
Sedimentation equilibrium data for REI-RGD4
in terms of equation 3b. Experimental
conditions are the same as described in
Figure 4. (a) Distribution of residuals. (b) Fit
of the data to equation 3b. (c) Derived
distribution of species as a function of the
total monomer concentration as determined
by the fit of the data to the model.
The results described here suggest that IB formation
during REI VL secretion does not involve early, transient
intermediates. The aggregating species is clearly not fully
unfolded, having acquired the intradomain disulfide bond
prior to IB incorporation. At the same time, the correlation
of IB formation with thermodynamic stability would pre-
sumably not have been obtained unless the aggregating
species is unfolded enough to energetically resemble the
unfolded (high fluorescence) state populated in Gdn-HCl
and thermal unfolding studies in vitro. The Tm values of
the mutants giving elevated levels of IBs are in the same
range as the growth temperature of the E. coli at which
these experiments were done, 37°C.
We believe that the best interpretation for the data pre-
sented here is that periplasmic IB formation by REI VL
involves a late, equilibrium folding intermediate rather
than an early, transient intermediate. In the scheme
shown in Figure 8, preREI is transported across the
periplasmic membrane and proteolytically cleaved with
removal of the signal peptide. The protein rapidly folds
through a series of intermediates, culminating in the for-
mation of sufficient tertiary structure to allow intradomain
disulfide formation across the b-sandwich. This folding
intermediate matures—perhaps through a series of further
equilibrium intermediates—to the native state. The
folded states of N2 and N remain in equilibrium with ISS,
however, so that a particular combination of sequence-
specific folding stability and cell growth temperature
allows sufficient ISS to be populated that it can sustain the
off-pathway reactions of IB formation.
This model is supported by the correlation of IB formation
with thermodynamic stability (Fig. 7) and by the observa-
tion that REI molecules in periplasmic IBs contain their
intramolecular disulfide bond. That it is a disulfide-
bonded intermediate, ISS, which is responsible for IB for-
mation is also consistent with the observation of the
Pluckthun group [35] that elevated levels of thiol-disul-
fide isomerase do not influence the extent of IB formation
in expression of immunoglobulin fragments. 
It remains possible that mutational effects on the matura-
tion rate of a transient folding intermediate may be
responsible for the IB effects seen in this system. For this
to be the case, however, two constraints would have to be
satisfied. First, the hypothetical intermediate would have
to contain the intradomain disulfide bond. Second, the
mutational effect on the folding rate would have to trans-
late into proportional mutational effects on DDGstab in
order to account for the correlation seen in Figure 7. It is
also possible that intracellular proteolysis plays a role in
84 Folding & Design Vol 1 No 2
Table 2
Properties of REI VL domains.
REI variant* % as IBs Cm‡ DDG, kcal mol–1‡ Tm, °C§ Kd, M.#
WT 18 1.55 0 55 7.5 ± 1 × 10–6 
RGD6† 39 1.3 1.1 48 7.9 ± 2 × 10–5
Q38D 33 1.41 1.2 51 8.0 ± 2 × 10–6
Q89R 69 1.15 1.8 47 <10–3
R61N 59 0.75 3.5 nd nd
RGD12 77 0.4 5.1 37 nd
RGD34 93 0.42 5.0 34 6.8 ± 2 × 10–6
RGD4 76 0.0 ≥6.9 25 K1→2, 1.3 ± 0.4 × 10–5
K2→4, 1.3 ± 0.1 × 10–6
*For structures of RGD loop swap mutants [17,18,24,25], see Fig. 6.
†RGD6 is G41R/K42G/A43D. ‡Some of this data is reproduced from
the literature [17,21]. The methods used to determine DDG and Cm
have been described [21]. §Data for WT, RGD12 and RGD34, and
the description of the method for determining Tm for the other mutants,
has been described [17,18]. #See Materials and methods and legends
to Figs 4,5. nd, Not determined.
Figure 6
Sequence changes introduced to produce the RGD loop swap
mutants described in this paper.
REI-VL WT ..YYCQQY-----QSLP------YTFGQ..

REI-RGD4  ..YYCQ-GKISRIPRGDMPDDRS--FGQ..
REI-RGD12 ..YYCQQY---RIPRGDMP----YTFGQ..



REI-VL WT ..TITCQA---SQD--IIKYLNWYQQTP..

REI-RGD34 ..TITCQARIPRGDMPIIKYLNWYQQTP..
(a)
(b)
20
90 100
40
influencing REI VL expression levels and/or distribution.
This possibility was not directly addressed in the studies
reported here.
If our interpretation of this data is correct, it implies that,
in the periplasmic expression of REI VL, IB mutants are
more analogous to ts mutations than to tsf mutations.
Although ts mutations have traditionally been interpreted
in the context of the two-state model for protein unfold-
ing, the genetics, biochemistry and cell biology of ts muta-
tions are consistent with any model in which the
aggregating species might be a statistical coil, an ordered
intermediate, or an alternative folded state, so long as it is
populated in the cell, at the critical temperature, in equi-
librium with the native state. In particular, it seems
increasingly unlikely that statistical coil states of globular
proteins are significantly populated in native buffer.
Ordered folding intermediates can be populated, in equi-
librium with the native state, in the transition zone of
thermal or solute-induced denaturation in vitro, and some
of these intermediates have been implicated in off-
pathway aggregation [36–38]. The distinction between ts
and tsf mutants, then, may be more a distinction between
the involvement of populated versus transient intermedi-
ates in off-pathway, protein misassembly reactions.
Even with the limited data presented here, it is clear that
there is no general correlation between IB formation and
the Kd for monomer/dimer equilibrium (see Results).
Although this implies that the folded monomer is not the
aggregating species, it does not mean that dimerization
energetics do not have a role in controlling IB formation.
According to Figure 8, an increased level of dimer forma-
tion, determined by the (steady-state) concentration of
REI VL in solution in the periplasm and by the mutant’s
Kd will contribute to protein stability and shift the pre-
equilibrium away from the aggregation-prone intermedi-
ate. The fact that REI VL Cm values determined at
solution concentrations favoring monomer correlate well
with IB formation suggests that dimerization either does
not play a major role, or it makes an equivalent energetic
contribution to all correlating mutants. Thus, the inability
to dimerize even at high protein concentration may
deprive the Q89→R mutant of additional stabilization
energy in the periplasm, which in turn might explain why
this mutant supports IB formation more readily than
expected on the basis of its monomeric DGstab (Fig. 7).
Recently, Knappik and Pluckthun [20] identified a
residue effect on IB formation in the E. coli expression of
the FV region (VL + VH) of the immunoglobulin
McPC603. When position 64 of the VH domain is occupied
by Ala, FV expression is poor and IBs containing at least
the VH domain accumulate. When this position is occu-
pied by Asp, soluble FV expression is dramatically
improved. Knappik and Pluckthun [20] found that this
trend in soluble expression does not correlate with the
effect of the sequence changes on folding stability of VH,
but does correlate with the sensitivity of the VH domains
to thermal aggregation in vitro. The results for VH expres-
sion are thus more consistent with the involvement of an
early folding intermediate. (However, the timing of disul-
fide formation in vivo was not assessed in their reported
experiments.) The results may differ from ours because of
the generally poorer solution behavior of the VH domain
compared with the VL domain [39,40].
The VL domain is also involved in the related human dis-
eases light chain amyloidosis and light chain deposition
disease (LCDD). As we have pointed out previously [7],
this allows for potentially instructive comparisons of the
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Figure 7
Correlation of thermodynamic stabilities of REI VL mutants with their
tendencies to form IBs during secretion expression in E. coli at 37°C.
Data from Table 2. 
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Figure 8
A model for off-pathway loss of soluble protein product in the secretion
expression of REI VL in E. coli. See Discussion.
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genetics of off-pathway aggregation for the same molecule
in humans and bacteria. Previously, our group reported
data suggesting that amyloidosis is associated with the
occurrence of one or more rare, destabilizing sequence
replacements which lead to the generation of an aggrega-
tion-prone, partially folded state under physiological condi-
tions [21]. Subsequently, we obtained evidence for a
similar explanation for LCDD [22]. According to our
working model for the human disease, folded VL is
released from the circulating immunoglobulin light chain
by limited proteolysis, after which it partially unfolds
according to its monomer/dimer equilibrium constant, its
concentration, and its unfolding free energy. Thus, despite
the fact that bacterial IBs form during biosynthesis whereas
human disease deposits form during light chain catabolism,
the general pathways of both misassembly processes may
involve similar, disulfide-bonded folding intermediates
populated in equilibrium with the native state .
The observation of a well behaved monomer/dimer/
tetramer equilibrium in REI-RGD4 is unexpected and
may be relevant to the higher aggregation processes con-
sidered here. By the criterion of intrinsic Trp fluores-
cence, the RGD4 mutant, which contains a long sequence
insert in CDR3, is not in a native, folded state in native
buffer at 25°C and pH 7 [17]. The molecule is probably
not fully unfolded, however, as the dequenched Trp is not
fully accessible to solute quenching [17]. The ultracen-
trifugation analysis presented here also suggests the exis-
tence of an alternatively folded state capable of well
behaved association phenomena. Whether the tetramer
formed in the ultracentrifuge is related to the higher
aggregates observed in VL IBs, amyloid fibrils, or LCDD
deposits is not clear at present. As a reasonably well
behaved, but non-native, associated form, it warrants
further study and may yield important clues to protein
misassembly processes.
Materials and methods
Construction of the REI secretion vector
A lac expression vector was constructed by deleting the DNA
sequence between 201–229 in pUC18 which contains the lacZ
Shine–Delgarno sequence, initiator Met and the first three codons of
lacZ. This was accomplished by PCR followed by the replacement of
the existing pUC18 fragment with the PCR deletion fragment. A
750 bp fragment was amplified from the vector using the upstream
primer 5′-CTAATCCTGTTACCAGTGGCTGCTG-3′ and the down-
stream primer 5′-ACCGAATTCGAAATTGTTATCCGCTC-3′ which are
complementary to 2157–2133 and 184–201, respectively, in the
pUC18 DNA sequence. In addition to the pUC18 sequences, the
downstream primer contains three extra bases (put in for efficient
restriction digestion), and an EcoRI site at the 5′ end which results in
the deletion of the sequences mentioned above. The fragment was
amplified using the GeneAmp Kit (PerkinElmer Cetus) following the
manufacturer’s specifications in a thermal cycler. The 750 bp amplifica-
tion product was phenol/chloroform extracted and ethanol precipitated
before digesting with EcoRI and AlwnI. Vector pUC18 with the HindIII
site deleted (HindIII removed by filling-in with Klenow followed by reli-
gation) was also digested with the same restriction enzymes and the
large ~1900 bp fragment was gel isolated and ligated with the
digested PCR amplified product. The construct with the lacZ deletion
is called pAE.
Design of the pelB secretion linker
The pelB DNA linker consists of 21 bp of 5′ upstream sequences con-
taining a putative Shine–Delgarno sequence, and DNA sequence
encoding the initiator Met and signal sequence from the pectate lyase
B gene from Erwinia carotovora [41]. Back translation of the pelB
protein sequence generated a possible DNA-encoding sequence
incorporating an NcoI site at the 3′ junction of the pelB signal so that
the REI synthetic DNA could be fused to the signal sequence in frame.
A MluI site, translation stops (in all three frames), SalI site, BssHII site,
plus a second set of translation stops and a trp a transcription termina-
tor were placed after the pelB sequence. The MluI site was inserted for
cloning the 3′ end of the synthetic REI DNA, and the SalI site was
inserted after the stop codons so the synthetic REI gene could be
moved to a number of available expression vectors as a NcoI–SalI frag-
ment. EcoRI and SphI restriction sites were placed at the 5′ and 3′
ends of the pelB linker, respectively, for cloning into the pAE vector.
The pelB linker was constructed from two synthetic oligonucleotides
97 bases in length with a 17 bp complementary region at the 3′ ends.
The single-stranded DNAs were annealed and converted into duplex
DNA by mutual primed synthesis using modified T7 polymerase
(Sequenase, US Biochemical) in the presence of all four dNTPs as
described elsewhere [42]. The duplex DNA was cleaved with EcoRI
and SphI and cloned into gel-purified pAE vector with the same restric-
tion ends to give vector placpelB.
The 322 bp REI NcoI–MluI fragment from vector pREIL [24] was
cloned into vector placpelB resulting in plasmid placREI. Although REI
was expressed and secreted under lac control, for comparison we also
constructed the corresponding tac vector, as follows. placREI was
digested with EcoRI and made blunt with mung-bean nuclease, and
then further digested with SalI to isolate the pelB-REI fragment shown
in Figure 9. The pelb-REI fragment was cloned approximately 40 bp
downstream of the Tac1 promoter transcriptional start site [43] in
vector pTac1I (K Valerie, unpublished data) which was previously
digested with NcoI, treated with mung-bean nuclease, and cut with SalI
to yield pTpREI, the final expression vector used to produce all the
secreted REI variants in this paper.
Expression of REI with the tac-pelB secretion vector
E. coli strain MM294 was used in plasmid maintenance as well as
expression. An overnight culture of MM294 transformed with the REI
variant plasmid was diluted 1:100 into LB media containing
100 mg ml–1 ampicillin and grown at 37°C with shaking. When the cells
reached an A600 of 0.8–0.9, IPTG was added to 1 mM final concentra-
tion and the resulting induction continued for 4 h before harvesting.
Isolation and purification of soluble REI
Wild-type and soluble REI VL mutants were isolated from a 2 l culture
of IPTG-induced MM294(pTPREI) cells A600 = 2.7 by osmotic shock.
Cells were harvested by centrifugation in a Sorvall GS-3 rotor at
8000 rpm for 15 min and frozen. The cell pellet was resuspended in
200 ml 20% sucrose, 25 mM Tris HCl, 1 mM EDTA, pH 8 and incu-
bated on ice for 15 min with occasional vortexing. The cellular suspen-
sion was then centrifuged at 10 000 rpm. The supernatant (sucrose
fraction) was saved. The remaining pellet was further extracted with the
addition of 200 ml ice cold water. The supernatant (water fraction) was
saved.
The water and sucrose fractions were batch absorbed to an Amberlite
XAD-7 resin (Sigma) which was added to the sucrose and water frac-
tions at 10% weight per volume. The Amberlite solution was rotated
slowly at RT for 2 h to allow the REI protein to absorb onto the resin.
The supernatant was then removed after the Amberlite had settled to
the bottom. To elute the proteins from the Amberlite, the resin was
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resuspended in 100 ml (one-half the original extraction volume) 50%
acetonitrile, 0.1% TFA and incubated at RT with slow rotation for
30 min. The eluant was diluted in water containing 0.1% TFA to reduce
the acetonitrile concentration to 10% (or dialyze directly into 10% ace-
tonitrile, 0.1% TFA), filtered (0.45 mm) and loaded onto a preparative
C4-protein reverse phase HPLC column. The acetonitrile gradient used
was 25–50% over a 50-min period with a flow rate of 4 ml min–1. Frac-
tions were collected at 1-min intervals and analyzed by HPLC and
SDS-PAGE gels to determine REI purity and yields.
Purification of REI mutants from inclusion bodies
The cell pellet from 2 l of induced cells was broken open using a
Rannie cell disrupter in 200 ml of cell suspension buffer (CSB; 20 mM
Tris, 1 mM EDTA, pH 8). The insoluble pellet was washed and then dis-
solved in 10 ml Gdn-HCl, 20 mM Tris HCl, 0.5 mM EDTA, pH 8. Mater-
ial that did not dissolve was removed by centrifugation. The
supernatant was diluted 1:4 in 1 M urea, 50 mM glycylglycine, 1 mM
EDTA, pH 8 and dialyzed into the same buffer at 4°C. Any precipitate
after dialysis was removed by centrifuging at 10 000 rpm in SS34
Sorvall rotor for 15 min. Amberlite was added 10% weight per volume
and similarly purified as the soluble REI proteins on the C4 prep
column. Alternatively, for IB preps only, the Amberlite step can be
omitted and the material taken directly to reverse phase HPLC, after
adjusting the pH with TFA.
REI variants collected from the HPLC were dialyzed into native buffers
10 mM sodium phosphate, pH 7.5 or 25 mM Tris-HCl, 50 mM NaCl,
1 mM EDTA, pH 7.5 before using in the various studies. Precipitated
material which occasionally accompanies this dialysis was removed by
centrifugation.
Detection of free cysteines in the REI inclusion bodies
The cell pellet from 1 l induced culture of pOTSRGD4 (cytoplasmic
IBs) or pTPRGD4 (periplasmic IBs) was resuspended in 100 ml ice
cold CSB and passed through the Rannie twice. Immediately after
lyzing, IAA was added to 40 mM. The IBs isolated in the pellet fraction
were washed and dissolved in guanidine buffer (see above) in the con-
tinued presence of 40 mM IAA. The RGD4 mutants were purified as
described above. Amino acid analysis or MS were used to detect any
carboxymethylated cysteines.
Estimation of inclusion body levels
Frozen cell pellets of induced cultures were lyzed in native buffer by
the procedure described in Lee et al. [24] or by the Rannie cell dis-
rupter. The soluble and insoluble fractions were loaded side by side in
defined proportions on a 15% SDS-polyacrylamide gel [44]. The pro-
teins on the gel were either visualized by Coomassie staining or
Western blotting. The REI bands were quantified using the densitom-
etry functions of an IS-1000 Digital Imaging System. SDS-PAGE esti-
mations of the percent protein in IBs were reproducible to within
10–15%.
Stability studies
Unfolding analyses were conducted by monitoring the fluorescence of
the single Trp residue in REI, which is quenched in the native state by
its close packing to the disulfide bond. The Gdn-HCl and heat-induced
protein unfolding was measured as described by Hurle et al. [21] and
Helms, Wetzel and co-workers [18], respectively.
Ultracentrifugation methods
At equilibrium, the concentration distribution of a single, homogeneous
species is exponential and is given by equation 1:
Mi (1 – v
–r) v2 (r2 – rm2)cr = co exp ( )+ base (1)2 R T 
where cr and co are the concentrations of the protein at a radial posi-
tion r and at a reference position, usually the meniscus, respectively. M
is the protein molecular weight, v– and r are the protein partial specific
volume and solvent density, v is the angular velocity, r is the distance in
cm from the center of rotation, rm is the radial position of the reference
position in cm, R is the universal gas constant, T is the absolute tem-
perature and base is a term describing non-sedimenting absorbance.
Equation 1 can be abbreviated as:
cr = c1 exp (s1) + base (2)
Mi (1 – v
–r) v2 (r2 – rm2)where s1 = ( )2 R T
For a self-associating system, i.e. A + A ↔ A2, equation 2 will have two
exponentials, one for the monomer and one for dimer:
cr = cmono exp (smono) + cdimer exp (sdimer) + base (3a)
For a monomer/dimer/tetramer model, equation 3a is extended to:
cr = cmono exp (smono) + cdimer exp (sdimer) + ctetexp (stet) + base (3b)
From the definition of the equilibrium constant:
cdimer
(cmono)2
K12
equation 3a may be re-written: 
cr = cmono exp (smono) +  
(cmono)2 exp (sdimer) + base (4)
K12
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Figure 9
Sequence of DNA in the tac expression vector
including Shine–Dalgarno region, pelB signal
peptide, and 5′ and 3′ termini of structural
gene. The figure shows the DNA sequence of
the 5′ untranslated region, which includes the
reported Shine–Delgarno sequence
(underlined), of the pectate lyase B gene and
its signal sequence followed by the 5′ and 3′
junctions of the REI gene found in the tac
expression vector. The coding sequence for
REI used in this construction is identical to
that described previously for the cytoplasmic
expression of REI [24].
tatttcaaggagacagtcataatgaaatatttattacctacagcagctgcaggcctgttattactcgctgcc

ataaagttcctctgtcagtattactttataaataatggatgtcgtcgacgtccggacaataatgagcgacgg	
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REI
From equation 4 it is clear that in fitting the sum of two exponentials,
one for the monomer and one for the dimer, the equilibrium constant,
K12, can be fit for, directly.
For a monomer/dimer/tetramer equilibrium, equation 3b would have the
form: 
(5)
After the data were fit to the above models, a profile analysis was done
to empirically determine the confidence intervals on the determined
parameters [28]. Global analyses were performed on all data reported
here and in all cases the models were functionally linear with respect to
all parameters. 
Transmission electron microscopy
Samples were fixed with 2% glutaraldehyde and 2% paraformaldehyde
in 0.1 M cacodylate buffer, pH 7.3 (‘buffer’), rinsed with buffer, post-
fixed with 1% osmium tetroxide in buffer, rinsed with buffer and dehy-
drated with a graded series of ethanol (30–100%). Samples were
embedded in epoxy resin, ultrathin sections prepared and stained with
uranyl acetate and lead citrate, and examined with a JEOL 1200 EX
transmission electron microscope operating at 80 kV. 
Mass spectrometry
Matrix-assisted laser desorption mass spectrometry (MALDI-MS) data
for wild type and REI mutants were obtained on a Perseptive Biosys-
tems Voyager RP laser desorption linear time-of-flight mass spectrome-
ter. Samples were prepared for analysis by mixing 1–10 pmoles of
analyte 1:5 with 3,5-dimethoxy-4-hydroxy-cinnamic acid (Aldrich), pre-
pared as a saturated solution in 33% CH3CN/0.1% TFA. Apomyoglo-
bin from horse (Sigma) was included as an internal calibrant (MH+
16952.5 Da). Desorption/ionization was accomplished using a nitro-
gen laser (337 nm, 3 ns pulse). The accelerating voltage in the ion
source was 30 kV. Spectra were averaged over approximately 100
laser scans. Calibrations were carried out using a customized version
of IGOR Pro (WaveMetrics Inc., Lake Oswego, OR). In some cases, as
indicated in the text, parent ion molecular masses were determined by
electrospray MS [45].
Amino acid analysis
REI wild-type and mutant forms (5–10 mg amounts) were hydrolyzed in
vacuo under 6N HCl for 20 h at 110°C. 1–2 mg of the resulting
hydrolyzates were analyzed by ion-exchange amino acid analysis using
post-column ninhydrin detection on a Beckman 6300 analyzer
equipped with a System Gold data acquisition system.
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